Collaborations & Alliances
Related Searches:
Filter by:
631 - 645 of 1091 results
February 11, 2010
PAREXEL International and Proteome Sciences have formed an alliance focused on enhancing PAREXEL's biomarker capabilities for early phase clinical development.
Read More »
February 2, 2010
Abbott has entered an exclusive worldwide licensing agreement with Pierre Fabre SA to develop and commercialize h224G11, a preclinical monoclonal antibody targeting the cMet receptor for the potential treatment of cancer.
Read More »
February 2, 2010
Corning, Inc. and Sartorius Stedim Biotech have entered a marketing and branding collaboration to offer a full range of cell culture products through a combined product catalogue.
Read More »
January 29, 2010
Quintiles has entered into a strategic alliance with Movetis NV for the commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany.
Read More »
January 27, 2010
Jubilant Biosys Ltd., a subsidiary of Jubilant Organosys Ltd., and Endo Pharmaceuticals have expanded their drug discovery partnership in oncology, following the delivery of an early stage milestone.
Read More »
January 20, 2010
Wacker Chemie and MorphoSys have expanded their existing collaboration for the use of Wacker’s Esetec bacterial secretion technology.
Read More »
January 19, 2010
Maxygen, Inc.’s majority-owned subsidiary, Perseid Therapeutics LLC, has achieved a preclinical milestone under its collaboration with Astellas Pharma, triggering a $5 million payment to Perseid.
Read More »
January 19, 2010
Halozyme Therapeutics, Inc. has signed an exclusive, worldwide, contract research collaboration with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatol
Read More »
January 14, 2010
AstraZeneca and Korea-based CrystalGenomics have entered into a research collaboration to discover and develop a novel anti-infective for use as a potential antibacterial agent.
Read More »
January 13, 2010
Altea Therapeutics has entered into a partnership with KAI Pharmaceuticals for the preclinical and clinical development of certain KAI peptides using Altea’s PassPort Transdermal Delivery System.
Read More »
January 13, 2010
Novo Nordisk has initiated its first Phase I trial with a long-acting oral GLP-1 analogue (NN9924), triggering a $2 million milestone payment to development partner Emisphere Technologies.
Read More »
January 12, 2010
Microbix Biosystems and Therapure Biopharma have signed a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Read More »
January 11, 2010
WuXi AppTec has entered into a partnership with Qiagen to provide an integrated solution for molecular biomarker development, validation and personalized healthcare targets to their respective clients.
Read More »
January 7, 2010
Pfizer and Strides Arcolab entered a new collaboration under which Pfizer will commercialize off-patent sterile injectable and oral products in the U.S. through its Established Products Business Unit.
Read More »
631 - 645 of 1091 results
